The largest database of trusted experimental protocols

4 protocols using anti serbp1

1

Western Blot Analysis of Protein Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples of interest were lysed in RIPA buffer (Cell Signaling 9806) containing protease inhibitor cocktail (Roche 11836170001), 1 mM PMSF, and phosphatase inhibitor (Pierce A32957), unless noted otherwise. Protein lysate concentrations were normalized using Pierce BCA (Thermo 23225), and then reduced and denatured in sample buffer (Thermo 39000). Lysates were separated on Bio-Rad 4%–20% Mini-PROTEAN TGX precast gels, transferred via Bio-Rad Trans-Blot Turbo onto PVDF membranes (Bio-Rad 1704272), blocked in TBS-T (TBS with 0.1% Tween-20) containing 5% BSA, and probed overnight at 4°C with primary antibody. The next day, blots were washed in TBS-T and probed with HRP-linked secondary antibody (Cell Signaling 7076; 7074; Streptavidin-HRP 3999S) for 1 hour. Signal detection was performed using ECL substrate (Thermo 34577; 34095) and a Bio-Rad ChemiDoc MP imaging system. Blot images were digitally processed and analyzed in ImageJ. The primary antibodies used were as follows: anti-actinin (isoforms 1–4) (Cell Signaling 6487), anti-HA (Cell Signaling 14793), anti-IGF2BP2 (MBL RN008P), anti-PBCBP1 (Abcam 74793), anti-PCBP2 (MBL RN250P), anti-SERBP1 (Abcam 55993), anti-TCAP (BD 612328), anti-FLAG (Cell Signaling 2368), anti-GAPDH (Cell Signaling 2118) and anti-MYOM (mMaC myomesin B4 was deposited to the DSHB by Perriard, J.-C.).
+ Open protocol
+ Expand
2

Western Blot Analysis of Protein Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples of interest were lysed in RIPA buffer (Cell Signaling 9806) containing protease inhibitor cocktail (Roche 11836170001), 1 mM PMSF, and phosphatase inhibitor (Pierce A32957), unless noted otherwise. Protein lysate concentrations were normalized using Pierce BCA (Thermo 23225), and then reduced and denatured in sample buffer (Thermo 39000). Lysates were separated on Bio-Rad 4%–20% Mini-PROTEAN TGX precast gels, transferred via Bio-Rad Trans-Blot Turbo onto PVDF membranes (Bio-Rad 1704272), blocked in TBS-T (TBS with 0.1% Tween-20) containing 5% BSA, and probed overnight at 4°C with primary antibody. The next day, blots were washed in TBS-T and probed with HRP-linked secondary antibody (Cell Signaling 7076; 7074; Streptavidin-HRP 3999S) for 1 hour. Signal detection was performed using ECL substrate (Thermo 34577; 34095) and a Bio-Rad ChemiDoc MP imaging system. Blot images were digitally processed and analyzed in ImageJ. The primary antibodies used were as follows: anti-actinin (isoforms 1–4) (Cell Signaling 6487), anti-HA (Cell Signaling 14793), anti-IGF2BP2 (MBL RN008P), anti-PBCBP1 (Abcam 74793), anti-PCBP2 (MBL RN250P), anti-SERBP1 (Abcam 55993), anti-TCAP (BD 612328), anti-FLAG (Cell Signaling 2368), anti-GAPDH (Cell Signaling 2118) and anti-MYOM (mMaC myomesin B4 was deposited to the DSHB by Perriard, J.-C.).
+ Open protocol
+ Expand
3

Western Blot Analysis of Actin and SERBP1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysates were analyzed by Western blotting using the following primary antibodies: Anti-actin rabbit polyclonal (Abcam), anti-SERBP1 (Abcam) followed by the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody, and analyzed by chemiluminescence.
+ Open protocol
+ Expand
4

Transfection of miR-362-3p in cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-SERBP1 and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primary antibodies were purchased from Abcam (Cambridge, MA, USA) and CST (Cell Signaling Technology, USA), respectively. The miR-362-3p mimic, miR-362-3p inhibitor, and negative control (NC) (scrambled sequence) were synthesized by and purchased from Shenggong (Shanghai, China). The sequences are presented in Table 1. All these molecules were transfected into cells using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer’s protocol.

The sequence of miRNA

miRNASequence
miR-362-3p5’-AACACACCUAUUCAAGGAUUCA-3’
miR-362-3p mimics5’-AACACACCUAUUCAAGGAUUCA-3’
miR-362-3p inhibitor5’-UGAAUCCUUGAAUAGGUGUGUU-3’
miRNA NC (Scramble)5’-UUCUCCGAACGUGUCACGUTT-3’

NC, negative control

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!